Comprehensive Guide to Mononuclear Cells
Peripheral Blood Mononuclear Cells (PBMCs): Composition, Isolation and Use
Mononuclear cells are the leukocytes with a single, unlobed nucleus — lymphocytes and monocytes. Isolated from blood by density gradient centrifugation, they become PBMCs: the most widely used primary human immune cell preparation in research. This guide covers what a PBMC fraction contains and what it deliberately excludes, how the isolation works, the practical decisions that determine yield and viability, and how the populations are identified.
Browse PBMC marker antibodies →Key takeaways
- Mononuclear cells are leukocytes with a single unlobed nucleus — lymphocytes and monocytes. Granulocytes are excluded because their nuclei are multilobed.
- A PBMC preparation contains T cells, B cells, NK cells, monocytes and a small dendritic cell population. It contains essentially no granulocytes, erythrocytes or platelets.
- Separation works on density: PBMCs are less dense than 1.077 g/mL and band at the interface, while granulocytes and erythrocytes are denser and pellet below.
- That density overlap is why granulocyte contamination is the classic failure mode — and why it worsens in samples that have been stored or are from inflamed patients.
- Process blood within about eight hours. Longer delays reduce viability, cause monocyte activation and skew the subset ratios you go on to measure.
- Subsets are identified by CD3 for T cells, CD4 and CD8 for helper and cytotoxic subsets, CD19 for B cells, CD56 for NK cells and CD14 for monocytes.
- PBMCs are used for immunophenotyping, cytokine release and proliferation assays, ELISpot, and as starting material for cell therapy manufacture.
Contents
- What are mononuclear cells?
- What a PBMC fraction contains
- Isolation by density gradient
- Practical factors that decide yield
- Cryopreservation
- Identifying the populations
- Mononuclear cells in bone marrow
- Research and clinical applications
- Clinical interpretation
- Choosing marker antibodies
- Frequently asked questions
Antibodies for PBMC phenotyping
A PBMC preparation is only as useful as your knowledge of what is in it. The six markers below define the major populations and are the standard basis of a PBMC panel.
![FITC Anti-Human CD3 Antibody [OKT-3]](https://cdn11.bigcommerce.com/s-h68l9z2lnx/products/20028/images/606504/fitc-anti-human-cd3-antibody-okt-3-agel0057__97655.1707498205.386.513.jpg?c=2)
FITC Anti-Human CD3 Antibody [OKT-3]
Pan-T cell marker — the anchor of any PBMC panel and the gate that separates T cells from NK cells.
View product →![PE Anti-Human CD4 Antibody [RPA-T4]](https://cdn11.bigcommerce.com/s-h68l9z2lnx/products/20273/images/607117/pe-anti-human-cd4-antibody-rpa-t4-agel0400__93698.1707500206.386.513.jpg?c=2)
PE Anti-Human CD4 Antibody [RPA-T4]
Identifies helper T cells; also expressed at lower level on monocytes, so pair with CD3.
View product →![Purified Anti-Human CD8a Antibody [OKT-8]](https://cdn11.bigcommerce.com/s-h68l9z2lnx/products/237256/images/618709/purified-anti-human-cd8a-antibody-okt-8-agel0405__54134.1733542112.386.513.jpg?c=2)
Purified Anti-Human CD8a Antibody [OKT-8]
Marks cytotoxic T cells, giving the CD4:CD8 ratio used widely in immune monitoring.
View product →![PE/Cyanine5 Anti-Human CD19 Antibody [HI19a]](https://cdn11.bigcommerce.com/s-h68l9z2lnx/products/221533/images/605916/pecyanine5-anti-human-cd19-antibody-hi19a-agel3412__42196.1707496385.386.513.jpg?c=2)
PE/Cyanine5 Anti-Human CD19 Antibody [HI19a]
Pan-B cell marker, present from early development through to activated B cells.
View product →![FITC Anti-Human CD56 Antibody [MY31]](https://cdn11.bigcommerce.com/s-h68l9z2lnx/products/221418/images/606240/fitc-anti-human-cd56-antibody-my31-agel3297__09896.1707497361.386.513.jpg?c=2)
FITC Anti-Human CD56 Antibody [MY31]
NK cell marker — used with CD3 exclusion to separate NK cells from NKT cells.
View product →![Purified Anti-Human CD14 Antibody [18D11]](https://cdn11.bigcommerce.com/s-h68l9z2lnx/products/271025/images/694967/purified-anti-human-cd14-antibody-18d11-agel5021__36015.1774514134.386.513.jpg?c=2)
Purified Anti-Human CD14 Antibody [18D11]
Monocyte marker; with CD16 it resolves the classical, intermediate and non-classical subsets.
View product →What are mononuclear cells?
The term is morphological rather than functional. Leukocytes divide into those with a single, rounded, unlobed nucleus — the mononuclear cells — and the granulocytes, whose nuclei are segmented into lobes. Mononuclear cells comprise the lymphocytes and the monocytes.
That distinction sounds academic but it is the entire basis of the isolation method. Because granulocytes differ from mononuclear cells in density as well as nuclear shape, a density gradient separates the two, and the resulting fraction is defined by what floats rather than by any functional property.
Peripheral blood mononuclear cells — PBMCs — are simply the mononuclear cells recovered from circulating blood by this method. They are the most widely used primary human immune cell preparation in research, because a routine venous blood draw yields tens of millions of them.
What a PBMC fraction contains
Knowing the approximate composition matters, because most experiments measure a subset within a mixed population.
| Population | Approximate share of PBMCs | Principal marker |
|---|---|---|
| T cells | 45–70% | CD3 |
| B cells | 5–15% | CD19 |
| NK cells | 5–20% | CD56, CD3-negative |
| Monocytes | 10–30% | CD14 |
| Dendritic cells | under 2% | CD11c with HLA-DR |
Within the T cell compartment, roughly two-thirds are CD4-positive helper cells and one-third CD8-positive cytotoxic cells, giving the CD4:CD8 ratio of about 2:1 in health that is used as an immune monitoring parameter.
What is deliberately absent
Equally important is what a PBMC preparation does not contain:
- Granulocytes — neutrophils, eosinophils and basophils — are denser than the separation medium and pellet with the erythrocytes. So PBMC work says nothing about neutrophils, which are the most abundant leukocyte in blood.
- Erythrocytes pellet at the bottom. This is why haemoglobin and blood group antigens are irrelevant to PBMC preparations.
- Platelets are less dense than PBMCs and remain in the plasma layer above, though some carry over and can be reduced by a low-speed wash.
If neutrophils are the target, PBMC isolation is the wrong method — whole blood lysis or a dedicated granulocyte protocol is needed instead.
Isolation by density gradient
The original article left this section as an empty heading, yet it is the step everything else depends on. The method rests on one number: the separation medium has a density of about 1.077 g/mL, which sits between the density of mononuclear cells and that of granulocytes and erythrocytes.
The procedure in outline
- Dilute the blood with an equal volume of buffered saline. This lowers viscosity and improves separation sharpness.
- Layer carefully over the medium. The diluted blood must be laid on top without mixing — a disturbed interface is the commonest cause of a poor preparation.
- Centrifuge with the brake off, typically around 400 ×g for 30 to 40 minutes at room temperature. Braking abruptly remixes the layers and undoes the separation.
- Harvest the interface. After spinning, four layers are visible: plasma on top, then the whitish PBMC band at the interface, then the clear medium, then the granulocyte and erythrocyte pellet. Collect the interface band.
- Wash twice in buffered saline to remove residual medium, which is toxic to cells over time and interferes with downstream assays.
- Count and assess viability before use, since yield varies substantially between donors.
Why temperature matters
Separation is performed at room temperature, not cold. The medium’s density is temperature-dependent, so a gradient run at 4 °C separates at a different effective density and recovers a different — usually worse — fraction. The washes afterwards can be cold.
Practical factors that decide yield
| Factor | Why it matters | What to do | |
|---|---|---|---|
| Time from draw | Viability falls and monocytes activate with delay; subset ratios shift | Process within 8 hours, ideally within 4 | undefined |
| Anticoagulant | EDTA, heparin and citrate all work for isolation but differ downstream | Heparin or citrate for functional assays; EDTA chelates calcium and can impair some readouts | undefined |
| Temperature before processing | Cold promotes platelet and monocyte adhesion; warm accelerates loss | Hold at room temperature, not on ice | undefined |
| Interface disturbance | Mixing during layering carries granulocytes into the band | Layer slowly against the tube wall; use a gradient tube if available | undefined |
| Centrifuge braking | Deceleration remixes the separated layers | Brake off, or lowest setting | undefined |
| Donor inflammation | Activated granulocytes become less dense and co-band with PBMCs | Expect higher contamination; check purity by flow cytometry | undefined |
Granulocyte contamination is worth singling out because it is both the commonest defect and the easiest to miss. Activated neutrophils lose density and migrate into the mononuclear band, so a preparation from an inflamed or infected donor can be substantially contaminated while looking normal. Where purity matters, verify it rather than assuming it.
Cryopreservation
PBMCs are frequently banked so that samples from different timepoints can be assayed together, which removes batch effects from longitudinal studies.
- Freeze promptly in medium with 10% DMSO and a high serum content, at roughly 5 to 10 million cells per mL.
- Cool at about 1 °C per minute then transfer to liquid nitrogen. Storage at −80 °C is acceptable only briefly.
- Thaw rapidly and dilute the DMSO out immediately — DMSO is toxic at room temperature.
- Expect losses. Recovery is typically 60 to 80%, and not evenly distributed: monocytes and NK cells tolerate freezing less well than T cells, so post-thaw subset ratios differ from fresh.
That last point is the one most often overlooked. If an experiment compares fresh with cryopreserved samples, the differential survival of subsets is a confounder in its own right, independent of any biology being studied.
Identifying the populations
A PBMC preparation is a mixture, so almost any measurement needs the populations resolved. Flow cytometry is the standard approach, and a minimal panel uses the following:
| Marker | Identifies | Note |
|---|---|---|
| CD45 | All leukocytes | Useful as a gating anchor to exclude debris and any residual non-leukocytes |
| CD3 | All T cells | The primary lineage gate; also required to exclude T cells when identifying NK cells |
| CD4 | Helper T cells | Also expressed at lower level on monocytes, so must be combined with CD3 |
| CD8 | Cytotoxic T cells | Gives the CD4:CD8 ratio, normally around 2:1 |
| CD19 | B cells | Expressed through most of B cell development; CD20 is an alternative |
| CD56 | NK cells | Requires CD3 exclusion — CD3-positive CD56-positive cells are NKT, not NK |
| CD14 | Monocytes | With CD16, resolves classical, intermediate and non-classical subsets |
Two practical points. Always include a viability dye, because dead cells bind antibody non-specifically and generate false populations. And include the lineage-exclusion marker — omitting CD3 from an NK gate is the single commonest error in PBMC phenotyping, since it silently includes NKT cells in the NK count.
Mononuclear cells in bone marrow
The same density separation applied to bone marrow yields a bone marrow mononuclear cell fraction, but its contents are quite different. Alongside mature lymphocytes and monocytes it contains haematopoietic stem and progenitor cells, which are the reason the preparation is made at all.
Haematopoietic stem cells self-renew and differentiate into myeloid and lymphoid progenitors, which in turn generate erythrocytes, platelets, granulocytes, monocytes and lymphocytes. They are identified by CD34, and it is CD34-positive selection from the mononuclear fraction that underlies haematopoietic transplantation and much gene therapy manufacture.
So a blood-derived and a marrow-derived mononuclear fraction are not interchangeable, despite sharing a name and a method: one is a mature immune cell population, the other is enriched for progenitors.
Research and clinical applications
- Immunophenotyping. Quantifying subset frequencies and activation states, the most common single use.
- Cytokine release assays. Stimulating PBMCs and measuring secreted cytokines by ELISA or multiplex — widely used in vaccine and drug safety work.
- Proliferation assays. Measuring antigen-specific responses by dye dilution or thymidine incorporation.
- ELISpot and intracellular staining. Enumerating antigen-specific responding cells at single-cell resolution, including the interferon-gamma release assays used in tuberculosis testing.
- Cell therapy manufacture. PBMCs are the starting material for CAR-T and other engineered cell products, where T cells are selected, modified and expanded.
- Biobanking. Cryopreserved PBMCs allow retrospective analysis and batched assay of longitudinal cohorts.
Clinical interpretation
Mononuclear cell counts and ratios carry diagnostic information in several settings.
In blood, lymphocyte and monocyte counts form part of the differential white cell count. Lymphocytosis accompanies viral infection and lymphoproliferative disease; lymphopenia occurs in HIV infection, corticosteroid therapy and critical illness. Monocytosis appears in chronic infection and some myeloid malignancies. An inverted CD4:CD8 ratio is a long-standing marker of HIV progression.
In cerebrospinal fluid, pleocytosis means an abnormally raised cell count, and the cell type matters: a mononuclear (lymphocytic) predominance points toward viral or tuberculous meningitis, or an inflammatory process, whereas a neutrophil predominance suggests acute bacterial meningitis. The distinction guides initial management, which is why the differential rather than the total count is reported.
Interpretation belongs with the treating clinician; this article describes the biology and is not clinical guidance.
Choosing marker antibodies
Conjugated and purified antibodies against CD3, CD4, CD8, CD14, CD19 and CD56 — the markers that resolve a PBMC preparation into its constituent populations by flow cytometry.
Browse PBMC marker antibodies →Frequently asked questions
What are mononuclear cells?
Leukocytes with a single, unlobed nucleus — the lymphocytes and monocytes. Granulocytes are excluded because their nuclei are segmented into lobes. The distinction is morphological, but it is also what makes density separation possible.
What does a PBMC preparation contain?
T cells (45–70%), B cells (5–15%), NK cells (5–20%), monocytes (10–30%) and a small dendritic cell population. It contains essentially no granulocytes, erythrocytes or platelets.
Do PBMCs include neutrophils?
No. Neutrophils are granulocytes and are denser than the separation medium, so they pellet with the erythrocytes. If neutrophils are your target, use whole blood lysis or a dedicated granulocyte protocol instead.
How are PBMCs isolated?
By density gradient centrifugation. Diluted blood is layered over a medium of about 1.077 g/mL and spun with the brake off. PBMCs band at the interface; granulocytes and erythrocytes pellet below. The interface is harvested and washed.
How quickly must blood be processed?
Within about eight hours, ideally four. Longer delays reduce viability, activate monocytes and shift subset ratios — so a delayed sample can give a misleading phenotype even if the cells look acceptable.
Why is granulocyte contamination a problem?
Because activated granulocytes lose density and migrate into the mononuclear band. Samples from inflamed or infected donors are therefore more contaminated, and since the preparation still looks normal, purity should be verified rather than assumed.
Do cryopreserved PBMCs behave like fresh ones?
Not identically. Recovery is typically 60 to 80%, and monocytes and NK cells survive freezing less well than T cells — so post-thaw subset ratios differ from fresh. Comparing fresh with frozen samples introduces that as a confounder.
Recent Posts
-
Questions About Dilutions? A Real Example of How to Prepare Your ELISA Solutions
Quick answer A researcher preparing a Human IL-18 ELISA …6th Aug 2026 -
Red Blood Cell Peroxidase Interference in Competitive ELISA
QUICK ANSWER A researcher ran a competitive 2,3-bisphosphoglycerate (2,3-BPG) ELISA …4th Aug 2026 -
Sample Dilution Range Calculation for Competitive ELISA kits
Quick answer A competitive ELISA is running correctly when the blank (zero standard) gives the h …31st Jul 2026